Enzyme-linked immunosorbent assays for α-synuclein with species and multimeric state specificities
- PMID: 21658411
- DOI: 10.1016/j.jneumeth.2011.05.020
Enzyme-linked immunosorbent assays for α-synuclein with species and multimeric state specificities
Abstract
Abnormal intracellular deposition of aggregated α-synuclein is the characteristic feature of a number of neurological disorders, including Parkinson's disease (PD). Although α-synuclein is typically known as a cytosolic protein, a small amount is secreted by exocytosis in both monomeric and aggregated forms. The extracellular forms of α-synuclein in human body fluids, such as cerebrospinal fluid (CSF) and blood plasma, might be a diagnostic target for PD and related diseases. Here, we characterized a new set of monoclonal antibodies against α-synuclein, and using different combinations of antibodies, we established ELISA systems to specifically detect human α-synuclein, mouse and human α-synuclein together, and multimeric forms of α-synuclein in biological samples. By employing the Tyramide signal amplification method, the sensitivity of the assay was significantly improved to detect a concentration as low as ∼12.5 pg/ml. These assays might be useful tools for quantitative analysis of α-synuclein in various forms and with high sensitivity in diverse biological samples.
Copyright © 2011 Elsevier B.V. All rights reserved.
Similar articles
-
Sensitive and specific detection of α-synuclein in human plasma.J Neurosci Res. 2010 Sep;88(12):2693-700. doi: 10.1002/jnr.22417. J Neurosci Res. 2010. PMID: 20648655
-
Production of a monoclonal antibody, against human α-synuclein, in a subpopulation of C57BL/6J mice, presenting a deletion of the α-synuclein locus.J Neurosci Methods. 2010 Oct 15;192(2):268-76. doi: 10.1016/j.jneumeth.2010.08.010. Epub 2010 Aug 13. J Neurosci Methods. 2010. PMID: 20709102
-
An antibody with high reactivity for disease-associated α-synuclein reveals extensive brain pathology.Acta Neuropathol. 2012 Jul;124(1):37-50. doi: 10.1007/s00401-012-0964-x. Epub 2012 Feb 28. Acta Neuropathol. 2012. PMID: 22370907
-
Development of electrochemiluminescence-based singleplex and multiplex assays for the quantification of α-synuclein and other proteins in cerebrospinal fluid.Methods. 2012 Apr;56(4):514-8. doi: 10.1016/j.ymeth.2012.03.016. Epub 2012 Mar 23. Methods. 2012. PMID: 22465793 Review.
-
Controlling the mass action of alpha-synuclein in Parkinson's disease.J Neurochem. 2008 Oct;107(2):303-16. doi: 10.1111/j.1471-4159.2008.05612.x. Epub 2008 Sep 2. J Neurochem. 2008. PMID: 18691382 Review.
Cited by
-
ATP13A2/PARK9 Deficiency Neither Cause Lysosomal Impairment Nor Alter α-Synuclein Metabolism in SH-SY5Y Cells.Exp Neurobiol. 2014 Dec;23(4):365-71. doi: 10.5607/en.2014.23.4.365. Epub 2014 Dec 12. Exp Neurobiol. 2014. PMID: 25548536 Free PMC article.
-
Antibody-aided clearance of extracellular α-synuclein prevents cell-to-cell aggregate transmission.J Neurosci. 2012 Sep 26;32(39):13454-69. doi: 10.1523/JNEUROSCI.1292-12.2012. J Neurosci. 2012. PMID: 23015436 Free PMC article.
-
LGALS3 (galectin 3) mediates an unconventional secretion of SNCA/α-synuclein in response to lysosomal membrane damage by the autophagic-lysosomal pathway in human midbrain dopamine neurons.Autophagy. 2022 May;18(5):1020-1048. doi: 10.1080/15548627.2021.1967615. Epub 2021 Oct 6. Autophagy. 2022. PMID: 34612142 Free PMC article.
-
Anti-aging treatments slow propagation of synucleinopathy by restoring lysosomal function.Autophagy. 2016 Oct 2;12(10):1849-1863. doi: 10.1080/15548627.2016.1207014. Epub 2016 Aug 2. Autophagy. 2016. PMID: 27485532 Free PMC article.
-
Timed Release of Cerebrolysin Using Drug-Loaded Titanate Nanospheres Reduces Brain Pathology and Improves Behavioral Functions in Parkinson's Disease.Mol Neurobiol. 2018 Jan;55(1):359-369. doi: 10.1007/s12035-017-0747-4. Mol Neurobiol. 2018. PMID: 28875428
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
